• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常及恶性子宫内膜组织和乳腺组织中的内源性雌激素与雄激素

Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues.

作者信息

Thijssen J H, Blankenstein M A

机构信息

Department of Endocrinology, University Hospital, Utrecht, The Netherlands.

出版信息

Eur J Cancer Clin Oncol. 1989 Dec;25(12):1953-9. doi: 10.1016/0277-5379(89)90377-5.

DOI:10.1016/0277-5379(89)90377-5
PMID:2632276
Abstract

Because of a well-established mechanism of action, tissue concentrations of steroid hormones are thought to be more closely related than blood levels to the biological effects exerted by these hormones. The results of studies on oestrogen and androgen concentrations in malignant and normal breast tissues are presented. Normal fatty and epithelial breast tissues and malignant tumour samples which had been obtained from pre- and postmenopausal women of two countries (Poland and The Netherlands) differing in the incidence of this malignancy were studied. In both countries highly comparable oestradiol concentrations in the breast were found. The median hormone levels in tumour tissue of 0.65 pmol/g tissue did not change with age. They were significantly higher than in normal epithelial (0.48 and 0.25 pmol/g in pre- and postmenopausal women) and fatty tissues (0.54 and 0.19 pmol/g respectively). Particularly in postmenopausal women, hormone levels in tumour tissue were much higher than plasma concentrations, which are comparable in both populations. Oestrone levels decreased with age in normal and malignant breast tissues. In both countries median levels in normal and fatty tissues of premenopausal women were similar (1.10 pmol/g tissue) but higher than those in postmenopausal patients (0.45 pmol/g tissue. Significantly lower levels were found in the malignant tissue samples of Polish premenopausal women (0.70 pmol/g) than in Dutch women (1.05 pmol/g); similarly, after menopause the tissue concentrations were higher in Dutch (0.55 pmol/g) than in Polish (0.31 pmol/g) patients. Thus lower oestrone tissue levels were observed in tumours from the country with the lower incidence for breast cancer. In a comparable study of uterine tissues, obtained from pre- and postmenopausal women, higher oestradiol concentrations than in the breast were found, whereas estrone levels were very similar. The levels in the uterus did not correlate with those in the plasma; no relation with histology was observed. The results of androgen measurements in breast tissues were in agreement with the concept that, particularly, androstenedione and testosterone could play a role as substrates for local aromatization. Lower concentrations were observed in the tumours than in the normal and fatty tissues. More extensive investigations will be needed to clarify the role of local formation (aromatization, hydrolysis by sulphatase) of oestrogens in tissues and of the interconversion of less active (oestrone) to more active (oestradiol) oestrogens.

摘要

由于作用机制明确,人们认为类固醇激素的组织浓度比血液水平与这些激素所产生的生物学效应联系更为紧密。本文展示了对恶性和正常乳腺组织中雌激素和雄激素浓度的研究结果。研究对象为来自两个乳腺癌发病率不同的国家(波兰和荷兰)的绝经前和绝经后女性的正常脂肪和上皮乳腺组织以及恶性肿瘤样本。在这两个国家,均发现乳腺中雌二醇浓度具有高度可比性。肿瘤组织中激素水平的中位数为0.65 pmol/g组织,且不随年龄变化。它们显著高于正常上皮组织(绝经前和绝经后女性分别为0.48和0.25 pmol/g)和脂肪组织(分别为0.54和0.19 pmol/g)。特别是在绝经后女性中,肿瘤组织中的激素水平远高于血浆浓度,而这两个人群的血浆浓度具有可比性。在正常和恶性乳腺组织中,雌酮水平随年龄下降。在这两个国家,绝经前女性正常和脂肪组织中的中位数水平相似(1.10 pmol/g组织),但高于绝经后患者(0.45 pmol/g组织)。波兰绝经前女性的恶性组织样本中(0.70 pmol/g)的水平显著低于荷兰女性(1.05 pmol/g);同样,绝经后荷兰患者(0.55 pmol/g)的组织浓度高于波兰患者(0.31 pmol/g)。因此在乳腺癌发病率较低国家的肿瘤中观察到较低的雌酮组织水平。在一项对来自绝经前和绝经后女性的子宫组织的类似研究中,发现子宫中的雌二醇浓度高于乳腺,而雌酮水平非常相似。子宫中的水平与血浆中的水平无关;未观察到与组织学的关系。乳腺组织中雄激素测量的结果与以下概念一致,即特别是雄烯二酮和睾酮可能作为局部芳香化的底物发挥作用。在肿瘤中观察到的浓度低于正常和脂肪组织。需要进行更广泛的研究来阐明组织中雌激素的局部形成(芳香化、硫酸酯酶水解)以及活性较低的雌激素(雌酮)向活性较高的雌激素(雌二醇)的相互转化所起的作用。

相似文献

1
Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues.正常及恶性子宫内膜组织和乳腺组织中的内源性雌激素与雄激素
Eur J Cancer Clin Oncol. 1989 Dec;25(12):1953-9. doi: 10.1016/0277-5379(89)90377-5.
2
Determinants of tissue oestradiol levels in human breast cancer.人类乳腺癌组织中雌二醇水平的决定因素。
Cancer Surv. 1986;5(3):597-616.
3
Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.绝经后广泛性乳腺癌女性在长期地塞米松治疗期间的甾体性激素和催乳素
J Endocrinol. 1977 May;73(2):235-46. doi: 10.1677/joe.0.0730235.
4
Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.雌激素在正常和恶性人乳腺组织中的内源性浓度及亚细胞分布。
Cancer Res. 1985 Jun;45(6):2900-6.
5
[Oestrogens in the cell: differences between uterine and mammary tissue].[细胞中的雌激素:子宫组织与乳腺组织的差异]
Geburtshilfe Frauenheilkd. 1983 Jun;43 Suppl 1:36-41. doi: 10.1055/s-2008-1036591.
6
Plasma oestrogens in postmenopausal women with endometrial cancer.患有子宫内膜癌的绝经后女性的血浆雌激素
Br J Obstet Gynaecol. 1993 Dec;100(12):1115-9. doi: 10.1111/j.1471-0528.1993.tb15176.x.
7
Tissue androgens and the endocrine autonomy of breast cancer.组织雄激素与乳腺癌的内分泌自主性
J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):167-71. doi: 10.1016/0960-0760(92)90203-u.
8
Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons.
Gynecol Endocrinol. 1992 Mar;6(1):13-7. doi: 10.3109/09513599209081001.
9
Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.雌激素受体、17β-羟类固醇脱氢酶与人类乳腺癌中雌激素含量之间的关系
Steroids. 1979 Aug;34(2):217-25. doi: 10.1016/0039-128x(79)90050-3.
10
Oestrone sulphate, adipose tissue, and breast cancer.硫酸雌酮、脂肪组织与乳腺癌
Breast Cancer Res Treat. 1985;6(1):75-87. doi: 10.1007/BF01806013.

引用本文的文献

1
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.与识别具有内分泌干扰特性的物质相关的不良结局途径的发展 子宫腺癌作为不良结局
EFSA J. 2023 Feb 14;21(2):e07744. doi: 10.2903/j.efsa.2023.7744. eCollection 2023 Feb.
2
Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer.治疗前高体重指数与亚洲绝经前局部乳腺癌女性的不良生存相关。
J Cancer. 2021 May 27;12(15):4488-4496. doi: 10.7150/jca.59133. eCollection 2021.
3
Pre-diagnostic sex hormone levels and survival among breast cancer patients.
乳腺癌患者诊断前的性激素水平与生存。
Breast Cancer Res Treat. 2019 Apr;174(3):749-758. doi: 10.1007/s10549-018-05121-8. Epub 2019 Jan 2.
4
Passenger protein determines translocation versus retention in the endoplasmic reticulum for aromatase expression.乘客蛋白决定芳香化酶表达在内质网中的易位与保留。
Mol Pharmacol. 2014 Feb;85(2):290-300. doi: 10.1124/mol.113.090431. Epub 2013 Nov 26.
5
Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.雄激素受体和血清睾酮水平可识别绝经后乳腺癌的不同亚型。
BMC Cancer. 2012 Dec 14;12:599. doi: 10.1186/1471-2407-12-599.
6
A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk.人类 UGT2B4 基因上游区域平衡选择的特征及其对乳腺癌风险的影响。
Hum Genet. 2011 Dec;130(6):767-75. doi: 10.1007/s00439-011-1025-6. Epub 2011 Jun 10.
7
SNP discovery, expression and cis-regulatory variation in the UGT2B genes.UGT2B 基因中的 SNP 发现、表达和顺式调控变异。
Pharmacogenomics J. 2012 Aug;12(4):287-96. doi: 10.1038/tpj.2011.2. Epub 2011 Mar 1.
8
Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats.雌激素介导雌性 ACI 大鼠中极光激酶 A(Aurora-A)的过表达、中心体扩增、染色体不稳定及乳腺癌的发生。
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18123-8. doi: 10.1073/pnas.0408273101. Epub 2004 Dec 15.
9
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.尿苷二磷酸葡萄糖醛酸基转移酶对乳腺组织中雌激素的代谢失活:综述
Breast Cancer Res. 2004;6(6):246-54. doi: 10.1186/bcr936. Epub 2004 Sep 27.
10
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer.肿瘤雌激素含量与子宫内膜癌的临床形态学及内分泌特征
J Cancer Res Clin Oncol. 2003 Apr;129(4):245-9. doi: 10.1007/s00432-003-0427-9. Epub 2003 Apr 15.